Ann: Ceasing to be a substantial holder from Arix Bioscience, page-44

First 44 Last

Share
Profile

Follow
ChipLeigh

1,625 Posts.

301

06/11/20

22:16

Post #: 48700692
Share

Originally posted by burner_7: ↑

Not sure if this has been posted but does explain why Arix bio. sold their whole holding.

As per their September results preso (refer page 18-19 of attached) they pre planned to reduce from a 16 company portfolio to 11 and as a result they had to sell out of 5 companies and pharmaxis was indeed one preempted for the chopping block. The only way to do so for a small co. Like pxs is to do it on a high liquidity day like the Fed announcement.

It's fair to worry and good to understand the logic behind the selling of substantial holders, especially in this case due to it being on good news and being 100% of their holdings. But you'll find that their holding in pxs would be immaterial for them due to it being less that 2% of the total fum so the volume would probably be more important than the exit price.

That all said I believe anyone purchasing shares 10c or below will be cheering Arix had to sell off as there'd be no way you'd be getting such a low entry otherwise. An enterprise value of $4mill for a reasonably mature pharma with the talent, pipeline and cashflow of pxs seems ridiculously cheap and doesn't come around too often from my experience.

Anyway just my findings and opinion.. good luck!

Expand

That's why I bought in today under 10c... I am certain today was traders letting go of positions due to bigger sellers...

PXS Price at posting: 9.9¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner

PEK

Shenghe holds one-fifth of Peak Rare Earths, and using that weight, has scrapped a superior takeover offer

OCC

Orthocell jumps as nerve repair tech shows hope for erectile dysfunction post-prostate surgery

FBM

Future Battery Minerals identifies strong regolith gold anomalism at Canyon

3DA

Amaero's big move: Exclusive deal, big targets, and a lot on the line

First 44 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.5¢		Change 0.000(0.00%)		Mkt cap ! $40.80M

Open	High	Low	Value	Volume
2.6¢	2.6¢	2.5¢	$24.93K	965.4K

Buyers (Bids)

No.	Vol.	Price($)
3	465517	2.5¢

Sellers (Offers)

Price($)	Vol.	No.
2.6¢	4507845	10

View Market Depth

No.	Vol.	Price($)
3	465517	0.025
17	4812952	0.024
12	1316086	0.023
2	284041	0.022
1	4809	0.021

Price($)	Vol.	No.
0.026	4510298	10
0.027	1179247	10
0.028	899342	4
0.029	698755	4
0.030	1630138	4

Last trade - 11.19am 16/09/2025 (20 minute delay)

SNT (ASX) Chart

Ann: Ceasing to be a substantial holder from Arix Bioscience, page-44

Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner

Shenghe holds one-fifth of Peak Rare Earths, and using that weight, has scrapped a superior takeover offer

Orthocell jumps as nerve repair tech shows hope for erectile dysfunction post-prostate surgery

Future Battery Minerals identifies strong regolith gold anomalism at Canyon

Amaero's big move: Exclusive deal, big targets, and a lot on the line

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Ceasing to be a substantial holder from Arix Bioscience, page-44

Top Stories

Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner

Shenghe holds one-fifth of Peak Rare Earths, and using that weight, has scrapped a superior takeover offer

Orthocell jumps as nerve repair tech shows hope for erectile dysfunction post-prostate surgery

Future Battery Minerals identifies strong regolith gold anomalism at Canyon

Amaero's big move: Exclusive deal, big targets, and a lot on the line

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News